Investor · New York, NY
Michael Huber
Open Michael in the network graph →Capital
$59.3M
across filings
Active
Jan 2018
to Aug 2024
Most-connected co-filers (71)
Robert Langer · PITTSBURGH, PA5 sharedSteven L. Shores · Atlanta, GA5 sharedKyle P. Detwiler · NEW YORK, NY3 sharedRichard K. Thompson · Bethlehem, PA3 sharedTim J. Pollak · Bethlehem, PA3 sharedRichard Kravitz · New York, NY3 sharedWilliam Golden · Pittsburgh, PA3 sharedIrvin Kessler · Plymouth, MN3 sharedLeland K. Carter · Bethlehem, PA3 sharedKeith K. Caldwell · Bethlehem, PA3 sharedDonald Wagner · Pittsburgh, PA3 sharedChristopher T. Pierson · Maitland, FL3 sharedTerence Golden · Pittsburgh, PA3 sharedJeffrey Au · Kowloon, Hong Kong, Hong Kong3 sharedAndrew Carney · Plymouth, MN3 sharedChris P. Sim · NEW YORK, NY3 sharedTimothy B. Tully · NEW YORK, NY3 sharedBruce C. Sanders · Atlanta, GA3 sharedCharles Mann · Fort Wayne, IN3 sharedAndrew J. Spokes · San Francisco, CA3 sharedAbraham R. Cambridge · Cape Town, T33 sharedWilliam England · Plymouth, MN3 sharedDon Seymour · Plymouth, MN3 sharedTeresa K. Tsou · Bethlehem, PA3 shared Recent filings (14)
Noveome Biotherapeutics, Inc.Aug 2024 · 23 co-filers$51.3MNoveome Biotherapeutics, Inc.Aug 2023 · 22 co-filers$40.2MOTSFD InvestCo, LLCJan 2023 · 1 co-filer$355KOTSFD InvestCo, LLCJan 2023 · 1 co-filer$355KLavien TV Partners LLCFeb 2021 · 4 co-filers$26.3MNoveome Biotherapeutics, Inc.Oct 2020 · 14 co-filers$15.0MLavien Partners, LPJul 2020 · 6 co-filersPuris Proteins, LLCAug 2019 · 17 co-filers$75.0MLavien Partners, LPMay 2019 · 6 co-filersNoveome Biotherapeutics, Inc.Apr 2019 · 17 co-filers$15.0MPuris Proteins, LLCJun 2018 · 23 co-filers$12.5MLavien Partners, LPMay 2018 · 5 co-filersLavien Partners, LPMay 2018 · 5 co-filersPuris Proteins, LLCJan 2018 · 23 co-filers$25.0MNoveome Biotherapeutics, Inc.Jan 2018 · 14 co-filers$15.0MHargray Capital Holdings LLCJun 2015 · 23 co-filersHargray Capital Holdings LLCJun 2015 · 23 co-filers Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Michael in the interactive graph →